Impairment of NKG2D-Mediated Tumor Immunity by TGF-β

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.02689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

TGF-β Activation and Function in Immunity

Annual Review of Immunology
AllergyImmunology
2014English

Cutting Edge: Novel Priming of Tumor-Specific Immunity by NKG2D-Triggered NK Cell-Mediated Tumor Rejection and Th1-Independent CD4+ T Cell Pathway

Journal of Immunology
AllergyImmunology
2004English

Critical Interactions Between TGF-β Signaling/Elf, and E-Cadherin/Β-Catenin Mediated Tumor Suppression

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Smad4-Mediated TGF-β Signaling in Tumorigenesis

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2010English

TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling

Molecular Cell
Cell BiologyMolecular Biology
2009English

DHEA-induced Ovarian Hyperfibrosis Is Mediated by TGF-β Signaling Pathway

Journal of Ovarian Research
GynecologyOncologyObstetrics
2018English

Impairment of Cell-Mediated Immunity Functions by Dietary Zinc Deficiency in Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1979English

Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions

Journal of Immunology
AllergyImmunology
2012English

TGF-β Signaling Promotes Tumor Vasculature by Enhancing the Pericyte-Endothelium Association

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy